Prenatal Diagnosis · 1994 · 92 citations · 14 references
MedicineMaternal HealthObstetricsHigh-risk PregnancyMaternal-fetal MedicinePrenatal DiagnosisMaternal Age PatternsPregnancyPrenatal AssessmentPrenatal Risk AssessmentAdvanced AgeClinical Utility Of ScreeningMaternal Age DistributionMaternal Age EffectsPrenatal Diagnosis Of Down SyndromePrenatal Genetic ScreeningPrenatal Screening Decision-makingScreening In High-risk Pregnancies
We investigated the effect of maternal serum screening on the amniocentesis (AC) rate in women of advanced maternal age. The AC rate after maternal serum screening was compared in two groups of women with a singleton pregnancy, 855 women of 30-35 years and 98 of 36 years and older. In our population, 34.1 per cent of the women of 36 years or older were 'screen-positive' for Down syndrome. Only 41.2 per cent of these women chose to undergo AC as opposed to 88.2 per cent in the younger age group. Within the older age group, the tendency to avoid AC increased with increasing age. Maternal serum screening led to a significant decrease in the AC rate in the older women. In this group, a comparison between the 'a priori' and the calculated risk might have had more influence on the decision to undergo AC than being screen-positive or screen-negative as such. We conclude that maternal serum screening had a major effect on the AC rate in women of advanced maternal age. This is of importance in a society in which the average maternal age is steadily increasing.
14
Maternal serum screening for Down's syndrome in early pregnancy.
N J Wald, Howard Cuckle, J. W. Densem et al. · BMJ · 1988 · 974 citations · Full text
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
N J Wald, Anne Kennard, J. W. Densem et al. · BMJ · 1992 · 294 citations · Full text